SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 42,550
-100 (-0.23%)
Mar 27, 2026, 1:50 PM KST
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 3.35 trillion as of March 26, 2026. Its market cap has decreased by -7.98% in one year.
Market Cap
3.35T
Enterprise Value
3.16T
Revenue
651.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
42,550.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 3.35T, a decrease of -74.13%. That is a compound annual growth rate of -23.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 3.35T | -11.47% |
| Dec 30, 2025 | 3.78T | -4.31% |
| Dec 30, 2024 | 3.95T | -28.57% |
| Dec 28, 2023 | 5.53T | -2.04% |
| Dec 29, 2022 | 5.64T | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LigaChem Biosciences | 7.77T |
| SK Biopharmaceuticals | 7.61T |
| Peptron | 7.38T |
| HLB Co., Ltd. | 6.80T |
| Voronoi | 5.40T |
| OliX Pharmaceuticals | 3.79T |
| D&D Pharmatech | 3.44T |
| PharmaResearch | 3.35T |